1. Nava VE, Jaffe ES. The pathology of NK-cell lymphomas and leukemias. Adv Anat Pathol. 2005; 12:27–34.
Article
2. Oshimi K. Progress in understanding and managing natural killer-cell malignancies. Br J Haematol. 2007; 139:532–544.
Article
3. Suzuki R, Takeuchi K, Ohshima K, Nakamura S. Extranodal NK/T-cell lymphoma: diagnosis and treatment cues. Hematol Oncol. 2008; 26:66–72.
Article
4. Ko YH, Ree HJ, Kim WS, Choi WH, Moon WS, Kim SW. Clinicopathologic and genotypic study of extranodal nasal-type natural killer/T-cell lymphoma and natural killer precursor lymphoma among Koreans. Cancer. 2000; 89:2106–2116.
Article
5. Kwong YL. Natural killer-cell malignancies: diagnosis and treatment. Leukemia. 2005; 19:2186–2194.
Article
6. Al-Hakeem DA, Fedele S, Carlos R, Porter S. Extranodal NK/T-cell lymphoma, nasal type. Oral Oncol. 2007; 43:4–14.
Article
7. Kim KJ, Lee GH, Hong SS, et al. A case of duodenal relapse of Epstein-Barr virus-positive, CD56-negative extranodal NK/T-cell lymphoma, nasal type. Korean J Gastrointest Endosc. 2005; 30:204–209.
8. Sumi M, Tauchi T, Sashida G, et al. Natural killer cell lymphoma in the duodenum. Leukemia and Lymphoma. 2003; 44:201–204.
Article
9. Tsuzuki Y, Okamoto S, Takayama N, et al. Natural killer-like T-cell lymphoma appearing in the duodenum with recurrence in a variety of extranodal organs. Rinsho Ketsueki. 1999; 40:494–498.
10. Kim JH, Lee JH, Lee J, et al. Primary NK-/T-cell lymphoma of the gastrointestinal tract: clinical characteristics and endoscopic findings. Endoscopy. 2007; 39:156–160.
Article
11. Ko YH, Cho EY, Kim JE, et al. NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status. Histopathology. 2004; 44:480–489.
Article
12. Cogliatti SB, Schmid U. Who is WHO and what was REAL? Swiss Med Wkly. 2002; 132:607–617.
13. Kern WF, Spier CM, Hanneman EH, Miller TP, Matzner M, Grogan TM. Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement. Blood. 1992; 79:2432–2437.
14. Wong KF, Chan JK, Ng CS, Lee KC, Tsang WY, Cheung MM. CD56 (NKH1)-positive hematolymphoid malignancies: an aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules, and angiocen-tricity. Hum Pathol. 1992; 23:798–804.
Article
15. Kim TM, Lee SY, Jeon YK, et al. Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group. Ann Oncol. 2008; 19:1477–1484.
Article
16. Liang X, Graham DK. Natural killer cell neoplasms. Cancer. 2008; 112:1425–1436.
Article
17. Oshimi K, Kawa K, Nakamura S, et al. NK-cell neoplasms in Japan. Hematology. 2005; 10:237–245.
Article
18. Musshoff K, Schmidt-Vollmer H. Proceedings: prognosis of non-Hodgkin's lymphomas with special emphasis on the staging classification. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1975; 83:323–341.
19. Kim YH, Lee JH, Yang SK, et al. Primary colon lymphoma in Korea: a KASID (Korean Association for the Study of Intestinal Diseases) study. Dig Dis Sci. 2005; 50:2243–2247.
Article